Show simple item record

dc.contributor.author Yau, Lorraine en_US
dc.date.accessioned 2007-05-18T20:03:39Z
dc.date.available 2007-05-18T20:03:39Z
dc.date.issued 2001-01-01T00:00:00Z en_US
dc.identifier.uri http://hdl.handle.net/1993/1919
dc.description.abstract Failure of revascularization procedures for the treatment of coronary artery disease, such as balloon angioplasty, typically occurs as a result of restenosis, a renarrowing of the lumen at the site of intervention. Restenosis is characterized by the formation of a neointimal lesion, a process that involves migration of smooth muscle cells from the medial to intimal region of a blood vessel followed by cell proliferation and extracellular matrix deposition. No intervention to date has proven to be clinically significant with regards to efficacy. As a result, a unique compound, MIBG, that inhibits post-translational modification of proteins associated with signal transduction pathways that modulate cell migration, proliferation and differentiation was investigated. H4IIE hepatoma cells were used to establish that MIBG inhibited cell growth and proliferation. MIBG was also shown to prevent differentiation of L6 skeletal myoblasts into myotubes, an effect that was reversible on removal of the compound. The effect of MIBG on differentiation was found to be a consequence of its action on the expression of key elements in the myogenic program. Smooth muscle cells are the primary cell type involved in the events leading to restenotic lesion formation, and studies with MIBG demonstrated that this compound is capable of inhibiting both smooth muscle cell migration and proliferation in response to growth factors and other stimulating agents. Furthermore, there was an indication that the compound may affect several signaling pathways in smooth muscle cells, as demonstrated by MIBG-dependent inhibition of PGE 2-mediated c-'fos' gene expression. An organ culture model of balloon angioplasty was used to show that MIBG is capable of inhibiting restenosis under controlled experimental conditions. Finally, femoral angioplasty ' in vivo' was sed to confirm the data generated with the organ culture model in a physiologically relevant system. MIBG significantly reduced neointimal formation in the injured regions of a porcine femoral artery when compared to arteries without MIBG treatment. These studies indicate that the inhibition of cell migration, proliferation and differentiation by MIBG may be beneficial in the treatment of restenosis post-angioplasty and therefore applicable to therapeutic intervention in a clinical setting. en_US
dc.format.extent 28121503 bytes
dc.format.extent 184 bytes
dc.format.mimetype application/pdf
dc.format.mimetype text/plain
dc.language en en_US
dc.language.iso en_US
dc.rights info:eu-repo/semantics/openAccess
dc.title Meta-iodobenzylguanidine, investigations into a mechanism of action and application to restenosis en_US
dc.type info:eu-repo/semantics/doctoralThesis
dc.type doctoral thesis en_US
dc.degree.discipline Physiology en_US
dc.degree.level Doctor of Philosophy (Ph.D.) en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics